Biomarin Pharmaceutical Inc (NAS:BMRN)
$ 67.32 0.25 (0.37%) Market Cap: 12.83 Bil Enterprise Value: 12.46 Bil PE Ratio: 40.31 PB Ratio: 2.37 GF Score: 69/100

Biomarin Pharmaceutical Inc Annual Shareholders Meeting Transcript

May 27, 2020 / 04:00PM GMT
Release Date Price: $106.7 (+2.85%)
Operator

Good morning, and welcome to the 2020 Annual Meeting of Stockholders of BioMarin Pharmaceutical Inc.

At this time, I would like to turn the conference over to Jean-Jacques Bienaimé, Chief Executive Officer and Chairman of the Board of BioMarin. Please go ahead.

Jean;Jacques BienaimÃ;BioMarin Pharmaceutical Inc.;Chairman;CEO

©,-&

Thank you. On behalf of the entire Board, our officers and employees, I want to welcome all of you to the Annual Meeting of Stockholders of BioMarin Pharmaceutical Inc. Our Board annually considers the appropriate format of our annual meeting. And this year, we decided to hold a virtual annual meeting due to the COVID-19 global pandemic. So I'm Jean-Jacques Bienaimé, Chief Executive Officer and Chairman of the Board of BioMarin, and I will be presiding at this meeting. Laura Woodhead, Vice President and Deputy General Counsel of the company, will act as Secretary of this meeting.

Within the virtual meeting platform, you will find a copy of the rules of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot